Joel Latham - Nov 28, 2023 Form 3 Insider Report for Incannex Healthcare Inc. (IXHL)

Role
CEO and President, Director
Signature
/s/ Joel Latham
Stock symbol
IXHL
Transactions as of
Nov 28, 2023
Transactions value $
$0
Form type
3
Date filed
12/6/2023, 06:05 AM
Next filing
Dec 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IXHL Common Stock 237K Nov 28, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 7.5K $3.29 Direct
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 7.5K $3.29 Direct
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 7.5K $3.29 Direct
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 7.5K $3.29 Direct
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 7.5K $3.29 Direct
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 7.5K $3.29 Direct
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 9.33K $17.10 Direct
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 9.33K $20.39 Direct
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 9.33K $23.02 Direct F1
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 9.33K $17.10 Direct
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 9.33K $20.39 Direct F2
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 9.33K $23.02 Direct F3
holding IXHL Stock Option (right to buy) Nov 28, 2023 Common Stock, par value $0.0001 15.8K $16.44 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted on November 28, 2023. Vesting to occur on June 30, 2024, provided Mr. Latham is still employed on such date.
F2 Granted on November 28, 2023. Vesting to occur on June 30, 2024, provided Mr. Latham is still employed on such date.
F3 Granted on November 28, 2023. Vesting to occur on June 30, 2025, provided Mr. Latham is still employed on such date.